David R. Holmes Jr, MDProfessor of Medicine, Mayo Clinic College of Medicine; Consultant, Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
David R. Holmes, Jr., MD is a Professor of Medicine at Mayo Clinic College of Medicine and Consultant, Department of Internal Medicine, Division of Cardiovascular Diseases at Mayo Clinic and Mayo Foundation. Dr. Holmes has also been named the Edward W. and Betty Knight Scripps Professor in Cardiovascular Medicine in honor of Dr. George M. Gura, Jr. He is also the Immediate Past President of the American College of Cardiology. He received his medical degree at Marquette University, Milwaukee, Wisconsin in 1971. He completed his internship at Virginia Mason Hospital, Seattle, Washington and his fellowship in Internal Medicine at Mayo Clinic, Rochester, Minnesota. He has also served in the United States Navy at the National Naval Medical Center, Bethesda, Maryland.
Dr. Holmes is responsible for many undergraduate and postgraduate educational activities at Mayo Clinic. He acts as editorial board member and is a reviewer of several professional journals including The American Journal of Cardiology, Journal of the American College of Cardiology, International Journal of Cardiology, and Catheterization and Cardiovascular Interventions. His special areas of interest include acute coronary syndromes, interventional cardiology, restenosis, vascular biology, risk outcomes analysis, and telemedicine as well as device occlusion of the left atrial appendage. In addition, he is involved in the development of new catheter design and new approaches for treatment of a wide variety of patients with coronary artery disease and vein graft disease. Finally, he is involved in the development of continued application of percutaneous coronary intervention technology to noncoronary vascular beds.
Recent Contributions to PracticeUpdate:
- Outcomes 2 Years After TAVR in Patients at Low Surgical Risk
- Outcomes Associated With Left Atrial Appendage Occlusion vs Direct Oral Anticoagulation in Atrial Fibrillation
- TMVR for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification
- Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries
- A Percutaneous Permanent Carotid Filter for Stroke Prevention in Atrial Fibrillation: The CAPTURE Trial
- Association of INR Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing PCI
- Device-Related Thrombus After Left Atrial Appendage Closure
- Left Atrial Appendage Closure for Embolic Prevention
- Changes in the Professional Lives of Cardiologists Over the Course of Two Decades
- Low Complication Rates Found With Watchman Left Atrial Appendage Closure Device